Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.
|Podcasts|September 12, 2022
Pharmacy Focus: Move the Needle Monday- Solving Common Vaccine Challenges with Motivational Interviewing
Motivational interviewing is a beneficial tool for health care providers to use for improving medication adherence, vaccine hesistancy, and more.
Advertisement
In this month's episode, John Beckner from NCPA speaks with Bruce Berger, PhD, FAPhA, President of Berger Consulting, LLC, about motivational interviewing in terms of solving common pharmacy issues, such as vaccine hesitancy and fatigue.
Advertisement
Related to this article
Early data suggest the 7 PCV20-added serotypes are causing a smaller share of invasive pneumococcal disease in children younger than 2 years.
The project maps how flu and HIV proteins enter cells, with the aim of developing longer-lasting vaccines.
Two Kidney Week 2026 abstracts show a dose-response link between cardiovascular-kidney-metabolic syndrome (CKM) stage and chronic kidney disease (CKD), while primary care clinicians cite evidence and workflow barriers.
In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.
The approval offers a once-weekly basal insulin treatment option for patients, reducing the frequency of injections.
In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.
A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Combined Cardiometabolic Biomarker Burden Tracks CKM Progression
2
Flu Vaccination Linked to Fewer Severe Outcomes in Older Adults, Fewer ED Visits in Children
3
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
4
FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D
5